Asundexian May Offer Safer Stroke Prevention in AF Patients New to Blood Thinners: OCEANIC-AF Analysis Medha Baranwal14 April 2025 9:00 AM ISTUSA: A recent subgroup analysis from the OCEANIC-AF randomized clinical trial highlights that asundexian, a novel oral Factor XIa inhibitor, may offer...
Asundexian Shows Lower Stroke Risk in oral anticoagulant Naive Patients: JAMA Dr Riya Dave31 March 2025 11:00 AM ISTResearchers have found in a new study that oral anticoagulants OAC-naive patients experienced a smaller increase in stroke or systemic embolism with...
Bayer Pharma gets CDSCO Panel nod to study Asundexian 50mg tablets Dr. Divya Colin29 Dec 2023 5:30 PM ISTNew Delhi: Bayer Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Phase III study of Asundexian in Atrial fibrillation stopped due to lack of efficacy: Bayer Ruchika Sharma20 Nov 2023 11:33 AM ISTBerlin: Bayer has announced that OCEANIC-AF, a phase III study investigating asundexian compared to apixaban (a direct oral anticoagulant) in...
Asundexian found to have reduced bleeding risk compared to apixaban in AF patients: Study Dr. Shravani Dali28 April 2022 9:15 AM ISTAsundexian was found to have reduced bleeding risk compared to apixaban in atrial fibrillation (AF) atrial fibrillationpatients, according to a...
Bayer Thrombosis drug Asundexian shows positive study result Ruchika Sharma5 April 2022 10:00 AM ISTAsundexian is a so-called factor 11a inhibitor and was being compared to a drug sold under the brand name Eliquis by Pfizer and Bristol-Myers Squibb...
Investigational Anti-Clotting Drug Asundexian cuts Bleeding Risk Among AF Patients: Lancet Dr. Kamal Kant Kohli5 April 2022 9:00 AM ISTDURHAM, N.C-A new type of anti-clotting drug Asundexian, caused fewer bleeding incidents among patients with atrial fibrillation than the commonly...
Bayer bags USFDA Fast Track Designation for asundexian Stroke Program Ruchika Sharma11 Feb 2022 1:10 PM ISTBerlin: Bayer has recently announced that the U.S. Food and Drug Administration (USFDA) has granted Fast Track Designation for its investigational...
